Program death inhibitors in classical Hodgkin’s lymphoma: a comprehensive review

Reyad Dada
  • Annals of Hematology, January 2018, Springer Science + Business Media
  • DOI: 10.1007/s00277-017-3226-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00277-017-3226-0

The following have contributed to this page: Reyad Dada

In partnership with: